SCHEMBL22255342

SCHEMBL22255342

c1ccc(-c2ccc3cc(-c4ccc(N(c5ccc(-c6cc7ccccc7c7ccccc67)cc5)c5cccc6sc7ccccc7c56)cc4)ccc3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.33
HSD17B2 P37059 2/20 0.33
CYP11B1 P15538 1/20 0.33
S1PR5 Q9H228 8/20 0.32
S1PR4 O95977 6/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
MPI P34949 1/20 0.32
KMT2A Q03164 1/20 0.32
GPR84 Q9NQS5 3/20 0.32
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22255765 0.97 HSD17B1 (0.33) HSD17B1HSD17B2CYP11B1S1PR5S1PR4
SCHEMBL23258733 0.97 S1PR5 (0.33) HSD17B1HSD17B2CYP11B1S1PR5S1PR4
SCHEMBL23258751 0.96 CYP11B1 (0.34) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23258075 0.96 CYP11B1 (0.35) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23258158 0.96 CYP11B1 (0.35) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23258752 0.96 CYP11B1 (0.35) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23258074 0.95 S1PR5 (0.34) HSD17B1HSD17B2CYP11B1S1PR5S1PR4
SCHEMBL22255684 0.94 CYP11B1 (0.35) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23225056 0.94 CYP11B1 (0.32) HSD17B1HSD17B2CYP11B1S1PR5S1PR4
SCHEMBL22255569 0.94 F9 (0.36) HSD17B1HSD17B2CYP11B1S1PR5S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235297-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235297-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA HSD17B1 617/4885HSD17B2 646/4885CYP11B1 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.